GPS Wealth Strategies Group’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50
Closed -$1.45K 1268
2023
Q4
$1.45K Hold
50
﹤0.01% 1135
2023
Q3
$1.34K Hold
50
﹤0.01% 1157
2023
Q2
$1.85K Hold
50
﹤0.01% 1119
2023
Q1
$1.56K Buy
+50
New +$1.61K ﹤0.01% 1137
2022
Q4
Sell
-50
Closed -$2K 464
2022
Q3
$2K Hold
50
﹤0.01% 1035
2022
Q2
$3K Hold
50
﹤0.01% 973
2022
Q1
$3K Hold
50
﹤0.01% 932
2021
Q4
$5K Hold
50
﹤0.01% 853
2021
Q3
$4K Hold
50
﹤0.01% 864
2021
Q2
$5K Hold
50
﹤0.01% 856
2021
Q1
$4K Buy
+50
New +$5.16K ﹤0.01% 789

Other funds holding FLGT

GPS Wealth Strategies Group's FLGT Position: Q1 2024 in Review

GPS Wealth Strategies Group sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 50 shares — an estimated $1.45K sold.

GPS Wealth Strategies Group first reported a position in FLGT in Q1 2021 and held it in 11 quarters. The position peaked at $5K in Q4 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • GPS Wealth Strategies Group reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 50 Fulgent Genetics shares in Q1 2024, an estimated $1.45K.
  • GPS Wealth Strategies Group first reported a position in Fulgent Genetics in Q1 2021 and held it in 11 quarters.
  • GPS Wealth Strategies Group's Fulgent Genetics position peaked at $5K in Q4 2021.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q1 2024, filed 30 Apr 2024.